Celyad (Belgium)

Recent papers from Celyad (Belgium)

1. Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumorsMolecular Therapy Oncology · 2025
2. Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALLFrontiers in Immunology · 2025
3. CAR T cells re-directed by a rationally designed human peptide tag demonstrate efficacy in preclinical modelsCytotherapy · 2025
4. Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-CellsInternational Journal of Molecular Sciences · 2025
5. Engineering strategies to safely drive CAR T-cells into the futureFrontiers in Immunology · 2024
6. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?Cells · 2024
7. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?2023
8. Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platformMolecular Therapy — Nucleic Acids · 2023
9. Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non–Gene-edited Allogeneic CAR T-Cell TherapyJournal of Immunotherapy · 2022
10. The integrated stress response promotes B7H6 expressionJournal of Molecular Medicine · 2019
11. Expression of tumor-associated antigens in breast cancer subtypesThe Breast · 2019
12. Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing StrategiesBioDrugs · 2019
13. Overcoming Target Driven Fratricide for T Cell TherapyFrontiers in Immunology · 2018
14. A dvanced M aterial Cath eter (AMCath), a minimally invasive endocardial catheter for the delivery of fast-gelling covalently cross-linked hyaluronic acid hydrogelsJournal of Biomaterials Applications · 2018
15. A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T CellsJournal of Visualized Experiments · 2018
16. A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T CellsJournal of Visualized Experiments · 2018
17. Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancerAnnals of Oncology · 2018
18. Optimization of cell growth on palmitoyl‐hyaluronan knitted scaffolds developed for tissue engineering applicationsJournal of Biomedical Materials Research Part A · 2018
19. Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeuticESMO Open · 2018
20. Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour typesBMJ Open · 2017